Australia, March 8 -- Roche Diagnostics Gmbh, owns the trademark (2508387) for 'COBAS DIRECT' till Nov. 19, 2034.
Status: protected:
Registered/protected
Classes: 5 [Chemical preparations for medical purposes; biological preparations for medical purposes; biochemical preparations for medical use; in vitro diagnostic preparations for medical use; diagnostic reagents for medical use; reagents for in-vitro laboratory use [for medical purposes]; diagnostic biomarker reagents for medical purposes.], 9 [Scientific apparatus and instruments; laboratory instruments [other than for medical use]; instruments for diagnosis [for scientific use]; quantitative polymerase chain reaction [PCR] instruments for scientific use; real-time polymerase chain reaction [PCR] instruments for scientific use; diagnostic apparatus for research laboratory use; research laboratory analyzers for measuring, testing and analyzing blood and other bodily fluids; laboratory instrument for the detection of pathogens and toxins in a biological sample for research use.] and 10 [Medical apparatus and instruments; testing apparatus for medical purposes; diagnostic apparatus for medical purposes; real-time polymerase chain reaction [PCR] instruments for medical use; diagnostic testing instruments for use in immunoassay procedure [medical]; immunochemical medical diagnostic testing apparatus for detecting and measuring antibody levels; apparatus for analysing substances [for medical use]; diagnostic apparatus for medical purposes used in medical laboratories.]
Type of Mark: Word
Date of Acceptance: Dec. 24, 2024
Registration Advertised: March 7
For further details contact F. Hoffmann-La Roche AG .
The original document can be viewed at: https://search.ipaustralia.gov.au/trademarks/search/view/2508387.
Disclaimer: Curated by HT Syndication.
